Pcv74 - Cost-Effectiveness Analysis of Rosuvastatin Compared to Atorvastatin in Spanish Patients at Moderate, High, and Very High Cardiovascular Risk
Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.620
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV